These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 1768268

  • 21. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
    Norman AB, Eubanks JH, Creese I.
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
    [Abstract] [Full Text] [Related]

  • 22. Muscarinic cholinergic receptor subtypes in human detrusor muscle studied by labeled and nonlabeled pirenzepine, AFDX-116 and 4DAMP.
    Kondo S, Morita T, Tashima Y.
    Urol Int; 1995 Mar; 54(3):150-3. PubMed ID: 7604457
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Increased function of inhibitory neuronal M2 muscarinic receptors in diabetic rat lungs.
    Belmonte KE, Jacoby DB, Fryer AD.
    Br J Pharmacol; 1997 Aug; 121(7):1287-94. PubMed ID: 9257905
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Rat hippocampal muscarinic autoreceptors are similar to the M2 (cardiac) subtype: comparison with hippocampal M1, atrial M2 and ileal M3 receptors.
    Richards MH.
    Br J Pharmacol; 1990 Apr; 99(4):753-61. PubMed ID: 1694463
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Muscarinic receptor subtypes in human and rat colon smooth muscle.
    Gómez A, Martos F, Bellido I, Marquez E, Garcia AJ, Pavia J, Sanchez de la Cuesta F.
    Biochem Pharmacol; 1992 Jun 09; 43(11):2413-9. PubMed ID: 1610405
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Differential regulation of bladder beta-adrenergic and muscarinic cholinergic receptors in experimental diabetes.
    Latifpour J, Nishimoto T, Marian MJ, Yoshida M, Weiss RM.
    Diabetes; 1991 Sep 09; 40(9):1150-6. PubMed ID: 1657672
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Characterization of muscarinic receptor subtypes on rat pancreatic acini: pharmacological identification by secretory responses and binding studies.
    Kato M, Ohkuma S, Kataoka K, Kashima K, Kuriyama K.
    Digestion; 1992 Sep 09; 52(3-4):194-203. PubMed ID: 1281128
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists.
    Xu J, Chuang DM.
    J Pharmacol Exp Ther; 1987 Jul 09; 242(1):238-44. PubMed ID: 3039110
    [Abstract] [Full Text] [Related]

  • 37. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB, Creese I.
    Mol Pharmacol; 1986 Aug 09; 30(2):96-103. PubMed ID: 3755499
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.